Compare ARK Genomic Revolution ETF (ARKG) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Infosys Limited — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Infosys Limited trades at $12.37 (market cap $50.55B). The key difference: Infosys Limited pays a 4.16% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Infosys Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | INFY | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $20.22 |
52-Week Low | $24.02 | $10.49 |
Market Cap | — | $50.55B |
Enterprise Value | — | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
